Prosecution Insights
Prosecution Insights
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §112 only | 1 (17%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUYNH, PHUONG N | 1 | 65.7% | +53.3% |
| MERTZ, PREMA MARIA | 1 | 71.5% | +36.1% |
| LUNDE, GRACE HENRY | 1 | 63.6% | +37.5% |
| KAUFMAN, CLAIRE M | 1 | 62.8% | +51.3% |
| PATTERSON, SARAH COOPER | 1 | 58.6% | +56.4% |
| MIDDLETON, DANAYA L | 1 | 43.5% | +53.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18612960 | Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs | HUYNH, PHUONG N | 238d overdue |
| 17914261 | MASKED IL12 FUSION PROTEINS AND METHODS OF USE THEREOF | PATTERSON, SARAH COOPER | 37d overdue |
| 18017319 | FUSION PROTEINS COMPRISING A LIGAND-RECEPTOR PAIR AND A BIOLOGICALLY FUNCTIONAL PROTEIN | LUNDE, GRACE HENRY | 32d overdue |
| 18265341 | HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF | MERTZ, PREMA MARIA | 5d |
| 17624541 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | MIDDLETON, DANAYA L | 6d |
| 17999469 | HETERODIMERIC Fc VARIANTS SELECTIVE FOR Fc GAMMA RIIB | KAUFMAN, CLAIRE M | 34d |
| Art Unit | Apps |
|---|---|
| 1674 | 3 |
| 1641 | 2 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18612960 | Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs | HUYNH, PHUONG N | 1641 | §103 | Non-Final OA | 238d overdue | Pending | Mar 21, 2024 |
| 18265341 | HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF | MERTZ, PREMA MARIA | 1674 | §112 | Non-Final OA | 5d | Pending | Jun 05, 2023 |
| 18017319 | FUSION PROTEINS COMPRISING A LIGAND-RECEPTOR PAIR AND A BIOLOGICALLY FUNCTIONAL PROTEIN | LUNDE, GRACE HENRY | 1641 | Other | Non-Final OA | 32d overdue | Pending | Jan 20, 2023 |
| 17999469 | HETERODIMERIC Fc VARIANTS SELECTIVE FOR Fc GAMMA RIIB | KAUFMAN, CLAIRE M | 1674 | §103 | Non-Final OA | 34d | Pending | Nov 21, 2022 |
| 17914261 | MASKED IL12 FUSION PROTEINS AND METHODS OF USE THEREOF | PATTERSON, SARAH COOPER | 1675 | §103 | Non-Final OA | 37d overdue | Pending | Sep 23, 2022 |
| 17624541 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | MIDDLETON, DANAYA L | 1674 | Other | Final Rejection | 6d | Pending | Jan 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial